Profile
| Metric | Value |
|---|---|
| Full Name | Haleon plc |
| Ticker | NYSE: HLN |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United Kingdom |
| IPO | |
| Indexes | Not included |
| Website | haleon.com |
| Employees | 24,561 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $10.27 | |
| Price, 1D Change | +1.58% | |
| Market Cap | $46B | |
| TTM Dividend Yield | 1.70% | |
| PE Ratio | - | |
| Beta | 0.22 | |
| Revenue | $14B | |
| Revenue, 1Y Change | +2.17% | |
| EPS | $0.40 | |
| EPS, 1Y Change | +42.65% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.06 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | HLN.V | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.40 | |
| EPS Estimate | $0.49 | |
| EPS Est. Change | +21.86% | |
| Revenue | $14.35B | |
| Revenue Estimate | $11.08B | |
| Revenue Est. Change | -22.79% | |
| Current Price | $10.27 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.45 | $0.28 | -37.42% | |
| $0.36 | $0.40 | +11.31% | |
| $0.49 | N/A | +21.86% | |
| $0.54 | N/A | +34.18% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $14.46B | $14.05B | -2.86% | |
| $11.22B | $14.35B | +27.98% | |
| $11.08B | N/A | -22.79% | |
| $11.61B | N/A | -19.10% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +8.68% | |
| Price, 3Y | +31.84% | |
| Market Cap, 1Y | +7.85% | |
| Market Cap, 3Y | +28.12% | |
| Revenue, 1Y | +2.17% | |
| Revenue, 3Y | +9.34% | |
| EPS, 1Y | +42.65% | |
| EPS, 3Y | -2.97% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $10.27 | |
| SMA 200 | $9.90 | |
| SMA 200 vs Price | -3.59% | |
| SMA 50 | $9.67 | |
| SMA 50 vs Price | -5.83% | |
| Beta | 0.22 | |
| ATR | $0.15 | |
| 14-Day RSI | 67.73 | |
| 10-Day Volatility | 13.19% | |
| 1-Year Volatility | 22.94% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.06 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 1.54% | |
| Total Dividend | $0.16 | |
| Dividends Paid | $728.48M | |
| Payout Ratio | 38.65% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $14.35B | |
| EPS | $0.40 | |
| Gross Profit | $8.72B | |
| Gross Margin | 60.75% | |
| Operating Profit | $2.82B | |
| Operating Margin | 19.64% | |
| Net Income | $1.88B | |
| Net Margin | 12.84% | |
| EBITDA | $3.35B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.63 | |
| Current Ratio | 0.98 | |
| Quick Ratio | 0.78 | |
| Interest Coverage | 5.97 | |
| - | ||
| Altman Z-Score | 2.89 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | - | |
| PB Ratio | 2.11 | |
| EV/EBITDA | - | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $20.28B | |
| Cash & Equivalents | $2.82B | |
| Total Assets | $42.98B | |
| Current Assets | $7.17B | |
| Total Liabilities | $22.66B | |
| Current Liabilities | $7.29B | |
| Total Debt | $12.68B | |
| Short Term Debt | $1.87B | |
| Accounts Payable | $4.65B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $11.54B | |
| Operating Expenses | $5.90B | |
| Cost Of Goods Sold | $5.63B | |
| SG&A | $5.69B | |
| D&A | $414.08M | |
| Interest Expense | $490.77M | |
| Income Tax | $555.95M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $2.94B | |
| CFI | $674.80M | |
| CFF | -$1.96B | |
| Capex | $406.42M | |
| Free Cash Flow | $2.53B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | → | |
| Morgan Stanley | → | |
| Argus Research | → | |
| Morgan Stanley | ||
| Argus Research | → | |
| Argus Research | ||
| Deutsche Bank |
Analyst sentiment
Institutional ownership
Screeners with HLN
Data Sources & References
- HLN Official Website www.haleon.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1900304/000155837025003368/0001558370-25-003368-index.htm
- HLN Profile on Yahoo Finance finance.yahoo.com/quote/HLN
- HLN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hln
FAQ
What is the ticker symbol for Haleon plc?
The ticker symbol for Haleon plc is NYSE:HLN
Does Haleon plc pay dividends?
Yes, Haleon plc pays dividends. The last payment was $0.06, with an ex-dividend date on August 15, 2025
What sector is Haleon plc in?
Haleon plc is in the Healthcare sector
What industry is Haleon plc in?
Haleon plc is in the Specialty & Generic Drug Manufacturers industry
What country is Haleon plc based in?
Haleon plc is headquartered in United Kingdom
When did Haleon plc go public?
Haleon plc initial public offering (IPO) was on July 25, 2022
Is Haleon plc in the S&P 500?
No, Haleon plc is not included in the S&P 500 index
Is Haleon plc in the NASDAQ 100?
No, Haleon plc is not included in the NASDAQ 100 index
Is Haleon plc in the Dow Jones?
No, Haleon plc is not included in the Dow Jones index
When was Haleon plc last earnings report?
Haleon plc's most recent earnings report was on July 31, 2025
When does Haleon plc report earnings?
The next expected earnings date for Haleon plc is February 25, 2026